David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...

Company’s affordable, benefit-rich flagship PPO plans now have 4 Star ratingFRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense) seeds and their oil, ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense ) seeds and their oil, ...

Clover Health (CLOV) stock gains and Humana (HUM) stock falls as the Centers for Medicare & Medicaid Services ...

Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member ExperienceFRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) ...

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.

Corn crops have a voracious appetite for nitrogen. Purdue University scientists are investigating whether mulching Kura ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $4.07 which represents a slight increase of $0.12 or 3.04% from the prior close of $3.95. The stock opened ...

Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...

Cramer emphasized his mission to guide individuals toward becoming more thoughtful investors, rather than impulsive traders.